The global peptide synthesis market is anticipated to grow at a considerable CAGR of 6.5% during the forecast period (2021-2027). High prevalence of chronic diseases such as cancer, diabetes, and obesity globally is boosting the market as peptides are being used in the treatment of these diseases. For instance, According to international diabetes federation, it is anticipated that the number of diabetes patients will rise to 643 million by 2030 and 541 million are at high risk of type 2 diabetes. Various peptide therapies are popular for treatment of type 2 diabetes. Furthermore, according to the national center for biotechnology information, it is anticipated that there will be 26 million rises in cancer patients by 2030 and 17 million deaths by cancer due to growth of population. Thus, the demand for peptides due to increasing prevalence is expected to rise, which will boost the market growth.
Browse the full report description of "Global Peptide Synthesis Market Size, Share & Trends Analysis Report by Technology (Solid Phase, Liquid Phase, and Hybrid and Recombinant), By Product(Equipment, Reagents, Consumables, and Others) By End-User (Pharmaceutical and Biotechnology Companies, Contract Development and Manufacturing Organizations, and Academic and Research Institutes) Forecast Period (2021-2027)" at https://www.omrglobal.com/industry-reports/peptide-synthesis-market
The increasing mergers and acquisition in the market are further supporting in the market growth. For instance, in October 2021, Biotage AB acquired ATDBio Ltd through a partnership agreement for approximately GBP 45m in cash and shares. The acquisition, which provides Biotage with expertise in highly complex DNA and RNA production, will allow accelerated expansion of the UK company’s activities.
Market Coverage
• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Technology
o By Product and Services
o By End-user
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Thermo Fisher Scientific Inc., Merck KGaA, GenScript Biotech Corp., Bachem Holding AG, AAPPTec, Gyros Protein Technologies, Vivitide, Advanced ChemTech, Syngene International Ltd., Lonza Group Ltd. and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Peptide Synthesis Market Report By Segment
By Technology
• Solid Phase
• Liquid Phase
• Hybrid ad Recombinant
By Product and Services
• Equipment
• Reagents
• Others
By End User
• Pharmaceutical ad Biotechnology Company
• Contract Development and Manufacturing Organization
• Academic and Research Institute
Global Peptide Synthesis Market Report By Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa